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1. Introduction 
In developed countries, the prevalence of both allergic disease (asthma) and autoimmune 
disorders such as Crohn’s disease (CD), multiple sclerosis (MS), and type 1 diabetes (T1D) is 
increasing. This trend seems to be inversely correlated to prominent decreases in infectious 
diseases such as measles, tuberculosis, and hepatitis A (Bach, 2002). Based on such 
epidemiological observations, the “hygiene hypothesis”, that exposure to infectious agents; 
i.e. bacteria, viruses, and parasites, especially in childhood, lowers the risk of later onset of 
immunological disorders, has attracted much attention. According to the hypothesis, a 
reduced exposure to infectious agents due to improved hygienic conditions in developed 
countries, urbanized areas, and/or a westernized lifestyle is responsible for the higher 
incidence of autoimmunity and allergies in modern society. A number of epidemiological 
and experimental studies have demonstrated the plausibility of this hypothesis. However, 
there is also considerable evidence that does not support or contradicts the hypothesis. In 
this chapter, conflicting reports are introduced and discussed. 
Most studies trying to elucidate the mechanisms involved have been conducted using 
rodent models. In various models of autoimmune or allergic diseases, effects of bacterial, 
viral or parasitic infections were tested. Consequently, in many cases, preventive or 
ameliorating effects of infectious agents have been confirmed. In the main part of this 
chapter, the influence of parasitic helminths on autoimmune disorders will be introduced. 
Although the mechanisms underlying the amelioration and/or prevention of 
immunological disorders by infectious agents have been studied extensively, they are not 
yet fully understood.  As both Th1-polarizing (bacteria and viruses) and Th2-polarizing 
(parasitic helminths) infectious agents have anti-autoimmune/anti-allergic activities 
(Zaccone & Cooke, 2011), the “Th1/Th2 paradigm” is not enough to explain the mechanisms 
involved.  Additionally, some autoimmune diseases have been shown to be dependent on a 
pathogenic T helper subset (Th17), and not on the Th1 subset. The suppressive mechanisms 
of infectious agents have been attributed to various regulatory/suppressive cell 
populations, such as Treg cells, Breg cells, NKT cells and alternatively activated 
macrophages (AA MΦs). In addition, the involvement of suppressive cytokines (e.g. IL-4, IL-
10 or TGF-β) has been studied and demonstrated. Focusing on helminth infections, the 
possible involvement of regulatory cells and cytokines is discussed.  
Some autoimmune diseases are being treated successfully with recently developed 
biological products (mainly humanized monoclonal antibodies against pro-inflammatory 
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cytokines). These products have outstanding therapeutic effects on autoimmune diseases 
(Nixon et al., 2007; Jones & Ding, 2010) compared to traditional immunomodulatory agents 
such as disease modifying anti-rheumatic drugs (DMARDs). However, they can cause 
severe adverse effects such as opportunistic infections. Helminths or their 
excretory/secretary products might solve the problems of monoclonal antibody therapy 
(Puneet et al, 2011). Therefore, at the end of this chapter, clinical trials of viable parasitic 
helminths for the treatment of immunological disorders are briefly introduced. 
2. Evidence of the hygiene hypothesis 
As described in Introduction, the prevalence of asthma, T1D, MS, and inflammatory bowel 
diseases (IBD) has been increasing in developed countries in an inverse relation to the 
declining prevalence of infectious diseases (Bach, 2002). In addition to the chronological 
trend, the geographical distribution of some autoimmune diseases seems to support the 
hygiene hypothesis. MS and T1D have a similar geographical distribution pattern known as 
a “North-south gradient”, with a high prevalence in northern European (Scandinavian) 
countries (= relatively hygienic) and low prevalence in southern European countries (= 
relatively non-hygienic) (Bach, 2002; Shapira et al., 2010a). This pattern could be explained 
by the hygiene hypothesis, but also attributable to differences in genetic background. For 
example, the single nucleotide polymorphism (SNP) PTPN22 is associated with high risk of 
T1D and distributed more in the northern regions than southern regions of Europe (Shapira 
et al., 2010a). Another factor that might explain the “North-south gradient” of MS and T1D 
is the amount of sun exposure. Vitamin D, production of which is dependent on exposure to 
UV, has been reported to have immunomodulatory effects, and insufficient production of 
vitamin D might be responsible for the higher incidence of autoimmune disorders in 
northern European countries (Shoenfeld et al., 2009; Ponsonby et al., 2002).  
There is epidemiological evidence of the importance of non-hygienic conditions in the 
prevention of autoimmune or atopic disorders. For instance, a significant difference in 
allergen-specific IgE level was reported between people of neighboring regions sharing the 
same ethnic background; Finland (relatively hygienic) and Russian Karelia (relatively non-
hygienic) (Seiskari et al., 2007). Enteroviral infections were found to protect the children in 
Karelia from atopy. Moreover, there are reports that offspring of immigrants from developing 
countries acquire a higher incidence of autoimmune diseases, such as T1D and MS, than the 
population of their parents’ motherland countries (Bach, 2002; Bodansky, 1992). These findings 
clearly indicate the importance of environmental factors (including hygienic standards) rather 
than genetic background in the pathogenesis of autoimmune disorders.  
The “sibling effect”, that children with more siblings have a lower risk of developing atopic 
disorders (Strachan, 1989), is the basic finding that the hygiene hypothesis comes from. The 
sibling effect on atopic disorders has been demonstrated in cohort studies (Benn et al., 2004; 
Matheson et al., 2009; Cullinan et al., 2003). A similar effect was reported in case of T1D 
(Cardwell et al., 2008a) and IBD (Koloski et al., 2008). From the viewpoint of the hygiene 
hypothesis, the decrease of the disease risk can be explained by the increased exposure to 
pathogens from elder siblings. Regarding atopic disorders, a meta-analysis of atopic 
dermatitis (AD) has shown inverse relationships with exposure to endotoxins, early day 
care, and contact with animals (Flohr et al., 2005). The risk of the early onset of allergic 
rhinitis (AR) was inversely correlated with viral infections during childhood, in addition to 
cumulative exposure to siblings before the age of 2 years (Matheson et al., 2009). Not only 
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overt infections but also non-invasive exposure to pathogen-derived products, such as 
endotoxins (Gereda et al., 2000), are considered responsible for prevention of atopy (von 
Mutius, 2007). In the case of autoimmune diseases, the risk of T1D is reduced in children 
living with siblings, sharing a bedroom and of households that often move (Cardwell et al., 
2008b). A population-based study in Canada demonstrated correlations between IBD and 
high socioeconomic status and low rates of enteric infections (Green et al., 2006). The report 
also revealed a positive correlation between IBD and MS.  
3. Evidence that does not match the hygiene hypothesis 
In great contrast to T1D and MS, rheumatoid arthritis (RA) has been declining in prevalence 
in recent decades (Gabriel &Michaud, 2009). Moreover, its geographical distribution is very 
different from that of T1D or MS. That is, RA is generally evenly distributed in the world 
and does not have a “North-south gradient”. (Shapira et al., 2010b). The geographical 
distribution of systemic sclerosis (SSc) seems to be contrast to those of T1D and MS. Within 
Europe, SSc is less frequent in the north than south (Shapira et al., 2010b). In the case of 
ankylosing spondylitis (AS), a genetic factor (HLA-B27) rather than environmental factors 
seems to explain the prevalence of the disease (Shapira et al., 2010b). Therefore, the 
geographical distribution and/or chronological transition of some autoimmune diseases 
cannot be explained by the hygiene hypothesis.  
For atopic disorders, the sibling effect itself has been confirmed (Benn et al, 2004; Matheson 
et al., 2009; Cullinan et al., 2003). However, some authors suggest that infections in early life 
do not explain the observed sibling effect (Benn et al., 2004; Cullinan et al., 2003). In a report 
on the preventive effects of endotoxins against AD (Flohr et al., 2005), apparent infections in 
early life were shown to increase the risk of AD. In a meta-analysis of relationships between 
exposure to furry pets and asthma and allergic rhinitis, there were different effects in 
different species of animals. That is, exposure to dogs increases the risk but exposure to cats 
decreases it (Takkouche et al., 2008). Moreover, in a meta-analysis of interrelationships 
between vaccinations with bacterial products (BCG and pertussis vaccine) and the incidence 
of asthma, no statistical association was found (Balicer et al., 2007). For T1D, there was no 
association between routinely recorded infections in early life and subsequent risk of the 
disease (Cardwell et al., 2008a). In addition, T1D had inverse relationships with asthma 
(Cardwell et al., 2003). These finding do not match the hypothesis that infections and 
exposure to pathogens protect against both atopy and autoimmunity. A systematic review 
of mycobacterial infections and atopy (Obihara et al., 2007) found that the negative 
correlations between them were mainly based on cross-sectional studies. The authors, 
therefore, claimed that population-based prospective studies would be needed. 
Regarding etiology of MS, two hypotheses have been proposed (Milo & Kahana, 2010). The 
“prevalence hypothesis” postulates that MS is caused by a pathogen common in high-
incidence areas. In contrast, according to the more accepted “poliomyelitis-hygiene 
hypothesis”, certain infections in early childhood protect against MS whereas infections 
with the same infectious agents later in life (e.g. adolescence) cause the disease, as in the 
cases of poliomyelitis. This concept is different from that of the “original” hygiene 
hypothesis, in that people living in hygienic conditions (= non-infected people) are 
protected from the disease. Epstein-Barr virus (EBV) is one of the infectious agents 
suspected to be causative of MS. Individuals infected with EBV in early childhood have a 
lower risk of MS than those infected in adolescence and as a consequence, suffer from 
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infectious mononucleosis (IM). Additionally, non-infected people are known to have the 
lowest risk of MS (Ascheiro & Munger, 2010), suggesting the plausibility of the 
poliomyelitis-hygiene hypothesis. In addition to the causal relationship betwen EBV and 
MS, a number of infectious agents (HCV, rotavirus, Coxsackie virus, HHV-6, Helicobacter 
pylori, Trypanosoma cruzi etc.) were reported to have an association with autoimmunity 
(Kivity et al., 2009; Getts & Miller 2010).    
Collectively, numerous reports seem to contradict the hygiene hypothesis. In the 99th 
Dahlem Conference on Infection, Dr. Matricardi tried to reconcile the conflicting evidence 
(Matricardi, 2010). For instance, infections with orofecal pathogens like hepatitis A virus 
(HAV) were shown to be inversely correlated with atopy whereas infections of airborne 
viruses (measles virus, mumps virus, rubella virus etc.) were not (Matricardi et al., 1997; 
Matricardi et al., 2000). He proposes gastrointestinal infections that stimulate immunological 
changes in gut-associated lymphoid tissue (GALT) to be important for protective effects 
against atopic diseases (Matricardi, 2010, Matricardi et al., 2000). Likewise, to explain why 
some microorganisms protect against immunological disorders and others do not, a refined 
version of the hygiene hypothesis, the “old friends hypothesis” has been proposed (Rook, 
2009). According to this hypothesis, immunological disorders develop if “old friends” 
(=microorganisms present in humans for a long time on the evolutionary time scale) are 
expelled from the body. Parasitic helminths and saprophytic bacteria are representative “old 
friends”. To avoid having to fight the host’s immune systems long term, they become 
relatively harmless and continuously activate regulatory dendritic cells (DCs) and 
regulatory T cells (Treg) at background levels. Consequently, the presence of “old friends” 
renders hosts resistant to immune dysregulation. This hypothesis seems very attractive, 
especially to explain immunoregulatory mechanisms by parasitic helminths. 
4. Influence of helminth infections on human autoimmune disorders 
There have been a few papers on the interrelationships between helminth infections and 
autoimmune diseases in humans. Correale and colleagues have reported the influence of 
helminth infections on MS. In a prospective, double-cohort study, they found that MS 
patients infected with helminths (Hymenolepis nana, Trichuris trichiura, Ascaris lumbricoides, 
Strongyloides stercolaris or Enterobius vermicularis) showed fewer exacerbations, reduced 
disability scores, and lower MRI activity compared with uninfected MS patients (Correale & 
Farez, 2007). Furthermore, the infected MS patients showed an increase in myelin basic 
protein (MBP)-specific IL-10 and TGF-ǃ - producing cells and a decrease in IL-12 and IFN-Ǆ - 
producing cells. B cells from helminth-infected MS patients tend to produce high levels of 
IL-10, brain-derived neurotropic factor (BDNF), and nerve growth factor (NGF) (Correale et 
al., 2008). More importantly, some MS patients who received anti-parasite treatment, due to 
an exacerbation of helminth-derived symptoms, showed an increase in MS activity (Correale 
& Farez, 2011). The authors also showed that both B cells and DCs from intestinal helminth-
infected MS patients had increased expression of TLR2 and some of immunological changes 
observed in helminth Ag-exposed cells were TLR2-dependent (Correale & Farez, 2009). 
Collectively, these results suggest that parasitic helminths have anti-MS activity in humans. 
Fleming & Cook (2006) summarized the relationship between prevalence of T. trichiura and 
MS at the country / regional level. According to the data, MS is prevalent only in T. 
trichiura-free countries. Regarding other autoimmune diseases, in a case-control study in 
Okinawa (Japan), S. stercolaris was less frequent in the autoimmune liver disease group than 
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control group, suggesting that the parasite might protect against autoimmune liver diseases 
(Aoyama et al., 2007). Most recently, Mutapi et al. (2011) reported epidemiological study in 
Zimbabwe on the interrelationships between Schistosoma haematobium infection and auto-
reactive antibody levels. They found an inverse relationship between infection intensity and 
anti-nuclear antibody (ANA) levels in schistosome- endemic areas. According to the study, 
anti-helminthic treatment significantly increased ANA levels.  
5. Influence of helminth infections on human atopic disorders 
Compared to studies on human helminth infections and autoimmunity, reports on the 
interrelationships between helminth infections and atopic disorders are much more 
common. However, as there is considerable variation in results among the reports, 
systematic reviews and meta-analyses are important. According to reviews of cross-
sectional studies on the relationships between current parasitic infections and athma and 
atopy (Leonardi-Bee et al., 2006; Flohr et al., 2009; Feary et al., 2011), both intestinal 
helminths (Hookworms, Ascaris, Trichuris, Strongyloides, Enterobius) and schistosomes 
significantly lowered reactivity in the skin prick test. In contrast, only hookworm infections 
lowered the risk of asthma significantly; odds ratio (OR) = 0.50 (Leonardi-Bee et al., 2006). It 
is worth noting that Ascaris infections heightened the risk of asthma (OR = 1.34). Other 
geohelminths had no significant effects on the risk of asthma.  
The evidence obtained in cross-sectional studies is indirect. Direct evidence of ameliorating 
effects of helminths can be obtained by intervention studies. According to the review 
literature above (Flohr et al., 2009), in some intervention studies, allergic skin sensitization 
increased after de-worming treatment. This finding was reproducibly observed in 
independent studies in Venezuela (Lynch et al., 1993), Gabon (van den Biggelaar et al., 2004) 
and Vietnam (Flohr et al., 2010). However, in a study in Ecuador (Cooper et al., 2006), there 
was no increase in the prevalence of atopy or clinical allergies after de-worming treatment. 
Furthermore, in the study in Vietnam (Flohr et al., 2010), the clinical symptoms of allergy 
did not worsen in the treated group despite the increased sensitization. Remarkably, a study 
in Venezuela (Lynch et al., 1997) showed a clinical improvement in asthma after regular anti-
helminthic treatment. Taken together with cross-sectional studies of allergies in helminth-
infected individuals, the overall results could be summarized as follows: 1) In general, 
parasitic helminths suppress skin sensitization. 2) However, parasitic helminths do not 
always suppress clinical allergies and can sometimes worsen allergic symptoms. Regarding 
the timing of helminth infections, a study in Brazil is especially noteworthy (Rodrigues et 
al., 2008). In the study, heavy infections with T. trichiura in early childhood were shown to 
reduce reactivity to allergens in later childhood. Even if the child was not infected at the 
time of the skin test, this protective effect was observed. Cooper et al. (2009) summarized 
studies on helminth infections and clinical allergies in a review, in which he stated that 
different helminths have different effects on allergies depending on the timing of exposure. 
According to the review, Trichuris and hookworms are protective, whereas Ascaris and 
Toxocara may be risk factors in certain situations. Further studies, especially de-worming 
intervention studies or therapeutic clinical trials using helminths, may be necessary to 
establish a general view of the anti-allergic effects of helminths. 
6. T cell subsets and autoimmunity 
Until several years ago, major autoimmune diseases such as MS, T1D, RA and CD and 
animal models thereof had been classified as Th1-dependent diseases. Recently, however, 
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the finding of a critical role for IL-23 in the pathogenesis of some experimental forms of 
autoimmune diseases (Cua et al., 2003; Murphy et al., 2003) and subsequent discovery of a 
pathogenic T cell subset producing IL-17 (Th17) (Langrish et al., 2005; Park et al., 2005) has 
led us to revisit the “Th1/Th2 paradigm”. The simplified “Th1/Th2 paradigm” still explains 
many immunological phenomena, but there is accumulating evidence of the importance of 
Th17 in the pathogenesis of autoimmunity. By using IL-17-deficient mice, essential roles of 
IL-17 in the pathogenesis of autoimmune disease have been demonstrated directly (Nakae et 
al., 2003a, 2003b; Komiyama et al., 2003). Development of the Th17 lineage is antagonized by 
both Th1-related cytokines (IL-12 and IFN-Ǆ) and a Th2 cytokine (IL-4) (Park et al., 2005; 
Nakae et al., 2007). Conversely, IL-23 and IL-17 negatively regulate Th1 differentiation 
(Nakae et al., 2007). Therefore, the balance of these Th subsets is much more complex than 
previously believed. Complicating the situation further is the recent finding that Th17 is not 
a stable subset and can be changed to the Th1 phenotype; i.e. plasticity of Th17 (Kurschus et 
al., 2010; Dong, 2011). The fate of Th17 cells depends on their surrounding environment 
(Dong, 2011; Lee et al., 2009) and Th17’s pathogenic nature depends on the conversion to 
Th1 cells, in the case of experimental T1D (Martin-Orozco et al., 2009; Bending et al., 2009). 
The relative importance of each Th subset to the pathogenesis may differ with the disease 
model, however in most cases, the pathogenicity of Th1 and Th17 is still under debate. There 
is a report that a transcription factor, T-bet, is essential for the encephalitogenicity of T cells 
rather than cytokine production (Yang et al., 2009). In contrast, T-bet seems to be a negative 
regulator in experimental autoimmune myocariditis (Rangachari et al., 2006). Given the 
unstable nature of the Th17 subset and disease heterogeneity of individual patients, 
antagonism of both the Th1 and Th17 subsets would be a better choice for the successful 
suppression of autoimmune diseases. From this viewpoint, parasitic helminths may have 
ideal immunomodulatory activities for treatment of autoimmunity.  
7. Effect of helminths on experimental autoimmunity 
7.1 Experimental autoimmune encephalomyelitis (EAE) 
EAE in rodents has been widely used as an animal model of MS. In EAE, both Th1 and Th17 
have been reported to be encephalitogenic and their relative importance depends on the 
mouse strain and MOG epitope used for immunization (El-behi et al., 2010). In addition, Th1 
and Th17 have different encephalitogenic roles as demonstrated by pathological 
observations; e.g., distinct cellular infiltrates (macrophage predominant or neutrophil 
predominant) and distinct sites of inflammation (mainly in the spinal cord or mainly in the 
brain) (El-behi et al., 2010; Domingues et al., 2010). These observations reinforce the 
necessity for an antagonistic effect against both Th1 and Th17 for ideal immunomodulatory 
medicines. 
Studies of therapeutic effects of helminths on EAE are summarized in Table 1. Anti-
encephalitogenic effects have been observed in all three groups of parasitic helminths; i.e. 
nematodes (Heligmosomoides polygyrus (Wilson et al., 2010), Trichinella spiralis (Gruden-
Movsesijan et al., 2008), Trichinella pseudospiralis (Wu et al., 2010) ), trematodes (Schistosoma 
japonicum (Zheng et al., 2008), Schistosoma mansoni (Sewell et al., 2003; La Flamme et al., 
2003), Fasciola hepatica (Walsh et al., 2009)) and cestodes (Taenia crassiceps) (Reyes et al., 2011).  
Among them, there are some distinct results in the effects of schistosomes. According to 
Sewell et al. (2003), the intra-peritoneal injection of schistosome eggs protected mice from 
EAE, whereas La Flamme et al. (2003), reported that a similar injection did not have 
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protective effect. In general, a down-regulation of both Th17 and Th1 cytokine expression 
has been demonstrated (Walsh et al., 2009; Wu et al., 2010; Reyes et al., 2011) except in 
papers published before the emergence of the Th17 concept (Sewell et al., 2003; La Flamme 
et al., 2003). Regarding cellular involvement in the suppression, B cells highly expressing 
CD23 were shown to be responsible for EAE suppression (Wilson et al., 2010) in adoptive 
transfer experiments. In that study, B cells from IL-10-deficient mice as well as from wild-
type mice conferred protection against EAE. The involvement of AAMΦ is also plausible, 
because AAMΦ markers are increased in the brain in T. crassiceps-infected EAE mice (Reyes 
et al., 2011). In addition, abrogation of schistosome-induced anti- encephalitogenic effects in 
STAT6-deficient mice (Sewell et al., 2003) might support the importance of AAM Φ. 
 
Helminth Treatment Proposed mechanism Refs
HƈƏƌƊƐƒƖƒƐƒƌƇƈƖ ƓƒƏƜƊƜƕƘƖ Adoptive transfer of
infected mouse cells
B cells, Independent of IL-10 Wilson et al., 2010
ŷƕƌƆƋƌƑƈƏƏƄ ƖƓƌƕƄƏƌƖ Infection Gruden-Movsesijan et al., 2008
ŷƕƌƆƋƌƑƈƏƏƄ ƓƖƈƘƇƒƖƓƌƕƄƏƌƖ Infection IL-17↓, IL-6↓, IL-1↓, IFN-↓, TNF-↓ Wu et al., 2010
ŶƆƋƌƖƗƒƖƒƐƄ ƍƄƓƒƑƌƆƘƐ Egg Ag i.p. IFN-↓, IL-4↑ Zheng et al., 2008
ŶƆƋƌƖƗƒƖƒƐƄ ƐƄƑƖƒƑƌ Egg i.p. IFN-↓, IL-4↑, TGF-↑, IL-10↑,
Dependent on STAT6
Sewell et al., 2003
Infection IL-12/23 p40↓, IFN-↓, TNF-↓, IL-4↑ La Flamme et al., 2003
FƄƖƆƌƒƏƄ ƋƈƓƄƗƌƆƄ Infection IFN-↓, IL-17↓, Dependent on TGF-,
Independent of IL-10
Walsh et al., 2009
ŷƄƈƑƌƄ ƆƕƄƖƖƌƆƈƓƖ Infection IL-17↓, TNF-↓, IL-4↑, IL-10↑ Reyes et al., 2011
AAM markers↑
↓：down-regulation, ↑：up-regulation  
Table 1. Suppressive effect of parasitic helminths on EAE. 
7.2 Experimental T1D 
Non-obese diabetic (NOD) mice have been used widely as an animal model of T1D. 
Spontaneous destruction of pancreatic ǃ-cells and subsequent hyperglycemia are observed 
in NOD mice. The pathogenesis of T1D in this mouse has been studied extensively, 
however, there is still considerable controversy over the relative contribution of Th1 (or IFN-
Ǆ) and Th17 (or IL-17). Anti-IFN-Ǆ treatment rendered NOD mice resistant to 
cyclophosphamide (CY)-accelerated diabetes (Debray-Sachs et al., 1991). In contrast, in IFN-
Ǆ deficient NOD mice, neither insulitis nor diabetes was prevented although the onset was 
delayed (Hultgren et al., 1996; Gysemans et al., 2008). These findings suggest that IFN-Ǆ is 
involved in, but not essential to, the pathogenesis. IFN-Ǆ is not itself detrimental to ǃ-cells, 
but induces apoptosis when acting with IL-1ǃ or TNF-ǂ (Gysemans et al., 2008). Regarding 
this pro-apoptotic effect, dual roles of IFN-Ǆ in NOD mice have been indicated; i.e. IFN-Ǆ 
induces ǃ-cell destruction via STAT-1 but protects ǃ-cells via IRF-1 (Gysemans et al., 2008). 
On the other hand, pathological roles of IL-17 have been also suggested in mice (Miljkovic et 
al., 2005: Emamaullee et al., 2009) and humans (Honkanen et al., 2010). Anti-IL-17 antibody 
prevented diabetes in NOD mice when administered around the time of onset (Emamaullee 
et al., 2009). At present, it is reasonable to conclude that both Th1 and Th17 play some role 
in diabetogenesis in NOD mice.  
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Along with NOD mice, inducible T1D models have been used for diabetes research. One of 
them is streptozotocin (STZ)-induced diabetes. STZ is a glucosamine- nitrosourea 
compound specifically toxic to pancreatic islet ǃ-cells (Yamamoto et al., 1981). Multiple low-
dose administrations of STZ cause immune mechanism-mediated ǃ-cell destruction and 
diabetes in mice (Kantwerk-Funke et al., 1991). In this T1D model, pathogenic roles of both 
IL-12/IFN-Ǆ axis (Herold et al., 1996; Müller et al., 2002; Gysemans et al., 2005; Cetkovic-
Cvrlje & Uckun, 2005) and IL-23/IL-17 axis (Miljkovic et al., 2005, Mensah-Brown et al., 
2006) have been suggested, as in NOD mice.  
 
T1D model Helminth Treatment Proposed mechanism Refs
Spontaneous T1D in NOD mice LƌƗƒƐƒƖƒƌƇƈƖ ƖƌƊƐƒƇƒƑƗƌƖ Infection, Worm Ag IL-4↑, IL-5↑, Treg Hübner et al., 2009
HƈƏƌƊƐƒƖƒƐƒƌƇƈƖ ƓƒƏƜƊƜƕƘƖ Infection Independent of IL-10 and Treg Liu et al., 2009
ŷƕƌƆƋƌƑƈƏƏƄ ƖƓƌƕƄƏƌƖ Infection IL-4↑, IL-10↑ Saunders et al., 2007
ŶƆƋƌƖƗƒƖƒƐƄ ƐƄƑƖƒƑƌ Infection / Egg i.p. Anti-insulin IgG↓ Cooke et al., 1999
Eggs, Egg Ag,
Worm Ag i.p.
NKT cells↑ Zaccone et al., 2003
Egg Ag i.p. Treg Zaccone et al., 2009
Streptozotocin-induced
diabetes in mice
ŶƆƋƌƖƗƒƖƒƐƄ ƐƄƑƖƒƑƌ Infection EL-Wakil et al., 2002
(Multiple low dose model)
ŷƄƈƑƌƄ ƆƕƄƖƖƌƆƈƓƖ Infection AAM Espinoza-Jiménez et al., 2010
↓：down-regulation, ↑：up-regulation  
Table 2. Suppressive effects of parasitic helminths on experimental T1D. 
Studies of the therapeutic effects of helminths on experimental T1D models are summarized 
in Table 2.  As in the case of EAE, all three groups of helminths (nematodes, trematodes and 
cestodes) have preventive effects against experimental T1D models. As Treg cells play an 
important regulatory role against diabetogenesis (Brode et al., 2006; Ott et al., 2005), some 
authors suggest that they are also responsible for the anti-diabetogenic effects of helminths 
(Hübner et al., 2009; Zaccone et al., 2009). However, other reports do not support the 
importance of Treg cells (Liu et al., 2009; Espinoza-Jiménez et al., 2010). This inconsistency 
probably suggests the presence of distinct suppressive mechanisms in each parasite species. 
In our recent study, intestinal helminth infection protected mice from diabetes induced by 
multiple low-doses of STZ in a STAT6-independent manner (unpublished observation). This 
finding suggests that immune polarization from Th1 to Th2 induced by helminths cannot 
explain the anti-diabetogenic effect. Further studies using gene-targeted mice are needed to 
elucidate the anti-diabetogenic mechanisms of helminths.  
7.3 Experimental autoimmune arthritis 
There are various models of autoimmune arthritis in rodents. Collagen-induced arthritis 
(CIA) is one of the most widely used classical models of RA (Stuart et al., 1982). In this 
model, anti-collagen antibodies are responsible for the destruction of cartilage (Terato et al., 
1992). Regarding cytokines, TNF-ǂ, IL-1β and IL-6 are crucial to the inflammatory bone 
destruction in autoimmune arthritis (Ferraccioli et al., 2010; Möller & Villiger, 2006). 
However, the most important factor in the bone destruction is receptor activator of NFκB 
ligand (RANKL). This cytokine is induced to express on osteoblasts and synovial fibroblasts 
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by IL-17 and acts on osteoclast precursors to stimulate their differentiation into 
multinucleated osteoclasts (Okamoto & Takayanagi, 2010). An essential role for IL-17 in the 
pathogenesis of CIA has been demonstrated directly by using IL-17-deficient mice (Nakae et 
al., 2003a). IL-17 is an essential pathological factor also in other models of arthritis; e.g. IL-1 
receptor antagonist-deficient mice (Nakae et al., 2003b), Ag-induced arthritis (AIA) (Irmler 
et al., 2007) and glucose 6-phosphate isomerase (GPI)– induced arthritis (Iwanami et al., 
2008). Thus, these models could be considered Th17-dependent. In contrast, IFN-Ǆ is now 
considered an ameliorating factor in CIA (Kelchtermans et al., 2009; Chu et al., 2007) and in 
AIA (Irmler et al., 2007). However, in proteoglycan-induced arthritis, IFN-Ǆ (not IL-17) is 
responsible for the pathogenesis (Doodes et al., 2008). Taken together, models of 
autoimmune arthritis are mainly dependent on Th17 but exceptions do exist. In human RA, 
the pathological importance of TNF-ǂ, IL-1β, IL-6 and IL-17 has been demonstrated directly 
by the striking efficacy of biological drugs targeting those cytokines (Nixon et al., 2007; 
Jones & Ding, 2010; Genovese et al., 2010). In addition, an anti-RANKL monoclonal antibody 
has been approved for osteoporosis and is now under clinical development for RA (Pageau, 
2009). 
As described in section 3, the global distribution and trends of RA do not match the hygiene 
hypothesis (Gabriel & Michaud, 2009; Shapira et al., 2010b). In addition, to our knowledge, 
there is no report of anti-RA effects of parasitic helminths in humans. Nonetheless, several 
investigators (including us) have found anti-arthritic effects of helminths or helminth-
derived products in rodents. Those studies are summarized in Table 3. We ourselves have 
reported suppressive effects of a blood fluke, S. mansoni, on mouse CIA (Osada et al., 2009). 
In that study, the S. mansoni infection reduced the severity of CIA as evaluated using scores 
of arthritis and numbers of arthritic paws. Histopathological observation revealed the 
prevention of bone destruction in the infected mice. According to an analysis of splenic 
cytokine production pattern, production of IL-17A, TNF-ǂ and IFN-Ǆ were down-regulated 
and that of IL-4 and IL-10 was up-regulated. The real-time PCR analysis of inflamed paws 
showed the striking augmentation of the gene expression of bone-absorptive pro-
inflammatory mediators (IL-1ǃ, IL-6 and RANKL) observed in non-infected arthritic mice to 
be abrogated in infected mice. S. mansoni is a gonochoristic worm and forms a pair in the 
portal vein. Egg deposition in the infected host organs is the major stimulus of Th2-
polarization (Grzych et al., 1991) and other immunomodulatory events such as Treg 
induction (Taylor et al., 2006). In our experiments, the severity of CIA correlated inversely 
with the numbers of worm pairs, theoretically proportional to the number of eggs produced 
(Osada et al., 2009). In addition, in a time-course experiment, the splenic cytokine 
modulation (including down-modulation of IL-17 and TNF-ǂ) was observed from 6 to 8 
week post-infection, which corresponds to the beginning of egg deposition (unpublished 
observation). However, repeated intra-peritoneal injections of soluble egg antigen (SEA) did 
not protect mice from CIA and viable eggs lost their ability to suppress IL-17 production by 
freeze-thawing and subsequent crushing treatment (Osada et al., 2010). Therefore, a viable 
infection, which supplies viable eggs continuously, may be essential for the schistosome-
induced anti-arthritic effects. By plotting the relationship between infection intensity and 
severity levels, we have found that a single pair of worms was enough to abrogate the 
augmentation of pro-inflammatory mediators and approximately 4 pairs were enough to 
suppress the onset of arthritis (Osada et al., 2009).  
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Arthritis model Helminth Treatment Proposed mechanism Refs
Collagen-induced arthritis
(CIA) in mice
AƖƆƄƕƌƖ ƖƘƘƐ Worm Ag i.p. Rocha et al., 2008
AƆƄƑƗƋƒƆƋƈƌƏƒƑƈƐƄ ƙƌƗƈƄƈ ES-62 i.p. IFN-↓, TNF-↓, IL-6↓, Anti-
collagen IgG↓
McInnes et al., 2003
ŶƆƋƌƖƗƒƖƒƐƄ ƐƄƑƖƒƑƌ Infection IL-17↓, TNF-↓, IL-6↓, RANKL
↓, Anti-collagen IgG↓
Osada et al., 2009
ŶƆƋƌƖƗƒƖƒƐƄ ƍƄƓƒƑƌƆƘƐ Infection IL-4↑, Anti-collagen IgG↓ He et al., 2010
Zymosan-induced arthritis
(ZYA) in mice/rats
AƖƆƄƕƌƖ ƖƘƘƐ Worm Ag i.p./p.o. NO↓, IL-1↓ Rocha et al., 2008
Adjuvant-induced arthritis
(AIA) in rats
ŶƆƋƌƖƗƒƖƒƐƄ ƍƄƓƒƑƌƆƘƐ rSj16 i.p. TNF-↓, IL-1↓,NO↓, IL-10↑ Sun et al., 2010
Spontaneous arthritis in
MRL/lpr mice
NƌƓƓƒƖƗƕƒƑƊƜƏƘƖ ƅƕƄƖƌƏƌƈƑƖƌƖ Infection Salinas-Carmona et al., 2009
HƈƏƌƊƐƒƖƒƐƒƌƇƈƖ ƓƒƏƜƊƜƕƘƖ Infection
FCA-induced
monoarthritis in rats
HƜƐƈƑƒƏƈƓƌƖ ƇƌƐƌƑƘƗƄ Infection IL-10 from CD4+ cells Shi et al., 2011
↓：down-regulation, ↑：up-regulation  
Table 3. Suppressive effects of parasitic helminths on experimental arthritis. 
In addition to the down-regulation of pro-inflammatory cytokines, pathogenic anti-collagen 
IgG levels were lowered in the infected mice. Since our publication, other investigators also 
have demonstrated therapeutic effects of schistosomes on arthritis models. He et al. (2010) 
showed that S.japonicum suppressed CIA. However, infection at 2 weeks before CIA 
induction resulted in an exacerbation of the disease, whereas infection at 7 weeks before 
induction prevented the disease. This is in contrast to our study in which infection at 2 
weeks before induction reduced the severity of CIA. The reason of this discrepancy is not 
clear, but as speculated by He et al., the difference in parasite species (S.mansoni and 
S.japonicum) might have affected the outcome. Sun et al. (2010) demonstrated that a 
recombinant protein of S. japonicum (rSj16) ameliorated adjuvant-induced arthritis in rats. 
The authors observed a suppression of IL-12 production and augmentation of IL-10 
production in rSj16-treated bone marrow-derived dendritic cells (BMDCs). A filarial 
nematode-derived phosphorylcholine- containing glycoprotein, ES-62, was proven to 
suppress ongoing CIA (McInnes et al., 2003). In vitro, ES-62 suppressed LPS-induced 
production of TNF-ǂ and IL-6 from RA synovial cells. Moreover, ES-62 also inhibited TNF-ǂ 
production in human T cells and macrophages. Regarding the involvement of regulatory 
cytokines and cells, Shi et al. (2011) reported that IL-10 from CD4+ cells of infected mice was 
important for anti-arthritic effects of the rat tapeworm Hymenolepis diminuta. They also 
found that the absence of IL-4Rǂ chain signaling in mice cancelled the anti-arthritic effects of 
the worm. These findings seem to suggest the importance of Th2-polarization by the 
parasite, however, we recently found that the Th2-polarizing intestinal parasite H. polygyrus 
did not protect mice from CIA but rather, exacerbated the disease (unpublished 
observation). The anti-arthritic mechanisms of helminths seem complicated, probably 
because of the heterogeneity of both experimental models and parasites.   
7.4 Experimental colitis as a model of IBD 
Human IBD includes heterogeneous inflammatory diseases of the intestines. For instance, in 
terms of T cell subset, CD had been considered a “Th1 disease”, but at present, the 
importance of the Th17 subset in the pathogenesis of CD is emphasized (Sarra et al., 2010). 
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Increases in both IL-17 and IL-12 mRNA in CD and UC patients has been reported (Nielsen 
et al., 2003). The most striking evidence of the involvement of IL-23/Th17 axis is the finding 
of Th17-related genes (including IL-23R gene) as susceptibility genes for CD (Brand, 2009).  
In contrast, Th2-related cytokines are dominant in UC (Sarra et al., 2010). Likewise, models 
of colitis are also composed of diseases with a distinct pathogenesis (Strober et al., 2002). 
Experimental colitis induced by the intra-rectal injection of hapten, such as TNBS or DNBS, 
resembles human CD and its development seems independent of IFN-ǄR (Camoglio et al., 
2000) and dependent on IL-17R signaling (Zhang et al., 2006). Colitis can be also induced by 
causing dysfunction in epithelial cell barrier. Supply of drinking water containing dextran 
sulfate sodium (DSS) induces this type of colitis. In this model, T and B cells are dispensable 
(Dieleman et al., 1994) and macrophages seem to play both a pathological role (Bauer et al., 
2010) and a regulatory role (Qualls et al., 2006; Smith et al., 2007). Considering predominant 
expression of Th2-related cytokines in the chronic phase, DSS-induced colitis resembles UC 
(Alex et al., 2009). Interestingly, neutralization of IL-17 aggravates the model (Ogawa et al., 
2004), suggesting that IL-17 plays a protective role against DSS-induced colitis. By contrast, 
another study demonstrated that the colitis was alleviated in IL-17A deficient mice (Ito et al., 
2008). The reason for this discrepancy is not clear, but might be due to different mouse 
strains used in their experiments as indicated by Ito et al. 
Using these models of colitis, a number of studies on helminth effects have been conducted 
(Table 4). Generally, helminths seem to ameliorate TNBS/DNBS- induced colitis. It is worth 
noting that even worms that usually cause intestinal pathology by laying a large number of 
eggs in the mesenteric vein (i.e. Schistosoma spp.) have anti-colitic effects (Moreels et al., 
2004; Ruyssers et al., 2009; Elliott et al., 2003; Mo et al., 2007; Zhao et al., 2009; Bodammer et 
al., 2011; Smith et al., 2007). A down-regulation of Th1/Th17-related cytokines and up-
regulation of anti-inflammatory cytokines are observed in most studies. However, only a 
few papers have provided direct evidence of the involvement of certain cells or cytokines.  
For instance, anti-colitic effects of S.mansoni (Elliott et al., 2003) and H.diminuta (Hunter et 
al., 2005) were demonstrated to be STAT6-dependent. The latter authors also a showed the 
anti-colitic effect of the worms to be dependent on IL-10 and the presence of macrophages 
(Hunter et al., 2010). In contrast to the regularly observed helminths’ ameliorating effects on 
Th1/Th17 dominant (TNBS/DNBS- induced) models, macrophage-mediated or Th2-
dominant (DSS-induced or oxazolone- induced) colitis was not alleviated or rather 
worsened by some helminth infections (Table 4). This exacerbation seems due to the robust 
Th2-polarization by the helminths; e.g. H. diminuta infection worsened oxazolone-induced 
colitis via IL-5 induction and consequently caused eosinophila (Wang et al., 2010), 
demonstrated by a loss of exacerbation in eotaxin-deficient mice or anti-IL-5 antibody-
treated mice. The finding that anti-colitic effects of schistosome male worms were lost in 
DSS-induced colitis when mice were infected with worms of mixed sex (Smith et al., 2007) 
may support the speculation, because the Th2-polarizing ability of schsitosome eggs 
(produced in mixed sex infection) is more potent than that of adult worms (Grzych et al., 
1991). Weinstock’s group has been studying anti-colitic mechanisms of the intestinal 
helminth H.polygyrus by using colitis in IL-10-deficient or TGF-ǃRII dominant negative (DN) 
mice (Elliott et al., 2004, 2008; Ince et al., 2009). According to the studies, the helminth’s anti-
colitic effect depends not on IL-10 but on TGF-ǃ signaling. This finding does not mean that 
host-derived TGF-ǃ is necessary, because it has been recently shown that H. polygyrus-
derived “TGF-ǃ-like molecules” mobilize host TGF-ǃ signaling and induce subsequent Treg 
cell development (McSorley et al., 2010; Grainger et al., 2010).  
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Colitis model Helminth Treatment Effect Proposed mechanism Refs
TNBS/DNBS-induced colitis AƑƆƜƏƒƖƗƒƐƄ ƆƄƑƌƑƘƐ Worm Ag i.p. A Ruyssers et al., 2009
HƈƏƌƊƐƒƖƒƐƒƌƇƈƖ ƓƒƏƜƊƜƕƘƖ Infection A Mast cell-mediated, Neural control of
secretory function
Sutton et al., 2008
ŷƕƌƆƋƌƑƈƏƏƄ ƖƓƌƕƄƏƌƖ Worm Ag i.r. A IL-1↓, iNOS↓, IL-13↑, TGF-↑ Motomura et al., 2009
ŶƆƋƌƖƗƒƖƒƐƄ ƐƄƑƖƒƑƌ Infection A IL-2↑, IL-4↑ Moreels et al., 2004
Egg i.p. A IFN-↓, IL-4↑, STAT6 dependent Elliott et al., 2003
Worm Ag i.p. A IFN-↓, IL-17↓, TGF-↑, IL-10↑ Ruyssers et al., 2009
ŶƆƋƌƖƗƒƖƒƐƄ ƍƄƓƒƑƌƆƘƐ Egg  i.p. A IFN-↓, IL-4↑, IL-10↑, Treg↑ Mo et al., 2007
Egg i.p. A IFN-↓, IL-10↑岝TLR4↓ Zhao et al., 2009
HƜƐƈƑƒƏƈƓƌƖ ƇƌƐƌƑƘƗƄ Infection A TNF-↓, IL-10↑, IL-4↑, AAM-
dependent,  IL-10/STAT6 dependent
Hunter et al., 2005;  Hunter et
al., 2010; Johnston et al., 2010
DSS-induced colitis AƑƆƜƏƒƖƗƒƐƄ ƆƈƜƏƄƑƌƆƘƐ Worm Ag / ES Ag i.p. A IFN-↓, IL-17↓, TNF-↓ Cançado et al., 2011
AƆƄƑƗƋƒƆƋƈƌƏƒƑƈƐƄ ƙƌƗƈƄƈ Cystatin i.p. A IL-10 producing M Schnoeller  et al., 2008
ŷƒƛƄƖƆƄƕƌƖ ƏƈƒƑƌƑƄ Galectin homologue i.p. A TGF-↑, IL-10↑ Kim et al., 2010
ŶƆƋƌƖƗƒƖƒƐƄ ƐƄƑƖƒƑƌ Infection (male only) A M dependent, Treg/IL-10/IL-4/IL-
13/TGF- independent
Smith et al., 2007
Infection (mixed) N
Egg Ag i.p. N
Infection (mixed) A TNF-↓ Bodammer et al., 2011
Egg Ag i.p. N
HƜƐƈƑƒƏƈƓƌƖ ƇƌƐƌƑƘƗƄ Infection E Reardon et al., 2001
Oxazolone colitis HƜƐƈƑƒƏƈƓƌƖ ƇƌƐƌƑƘƗƄ Infection E IL-5↑, Eosinophils↑ Wang et al., 2010
Piroxicam-induced colitis in
IL-10 deficient mice
HƈƏƌƊƐƒƖƒƐƒƌƇƈƖ ƓƒƏƜƊƜƏƘƖ Infection A IL-17↓, IL-10 independent Elliott et al., 2004; Elliott et al.,
2008
Colitis in TGF-RII DN mice HƈƏƌƊƐƒƖƒƐƒƌƇƈƖ ƓƒƏƜƊƜƏƘƖ Infection N TGF- signal dependent Ince et al., 2009
Rag/IL-10-/- Tcell transfer HƈƏƌƊƐƒƖƒƐƒƌƇƈƖ ƓƒƏƜƊƜƏƘƖ Infection A Modulation of DC岜function Hang et al., 2010
↓：down-regulation, ↑：up-regulation A: Amelioration, E: Exacerbation, N: No effect  
Table 4. Effects of parasitic helminths on experimental colitis. 
8. Clinical trials of parasitic helminths against immunological disorders  
The administration of non-pathogenic or hypo-virulent parasitic worms could be considered 
for the treatment of immunological disorders. Several clinical trials using parasitic worms 
have been and are currently being conducted. Significant therapeutic effects have been 
confirmed in some of these studies. Weinstock’s group conducted trials with Trichuris suis 
(porcine whipworm) ova (TSO) against CD (Summers et al., 2005a) and UC (Summers et al., 
2005b), and demonstrated significant efficacy. TSO is also being tested for MS and 
promising results have been obtained in a phase I trial (Fleming et al., 2011). Regarding 
allergic disorders, Bager et al. (2010) found no therapeutic effect of TSO on allergic rhinitis. 
However, Summers et al. (2010) critically commented on the report that it was premature to 
conclude that TSO is ineffective on allergic rhinitis because the TSO treatment was too late 
and not sufficient. Necator americanus (Hookworm) is also under clinical trials for asthma 
(Feary et al., 2010) and CD (Croese et al., 2006). The advantage of this worm is its long life in 
the host (at least 6 years) and no need for repeated inoculation (Elliott and Weinstock, 2009). 
The parasite was well-tolerated without severe adverse effects on asthmatic patients, but a 
safe dosage of the parasites (10 infective larvae) did not show significant therapeutic efficacy 
(Feary et al., 2010).  
www.intechopen.com
 
Parasitic Helminths as Potential Therapeutic Agents Against Autoimmune Disorders 
 
603 
9. Concluding remarks 
There are two ways of developing parasite-based biomedicines for clinical use. One 
approach is the direct applications of non-pathogenic/hypo-virulent viable helminths to 
patients, as introduced in section 8. In addition to TSO and hookworms, other hypo-virulent 
helminths could be considered for human application. However, before clinical trials, 
sufficient accumulation of epidemiological and experimental evidence of their therapeutic 
efficacy is required. Hypo-virulent intestinal nematodes (e.g. Trichostrongylus spp.), 
intestinal trematodes (e.g. Metagonimus sp.) and intestinal tapeworms (e.g. Hymenolepis 
diminuta) may become candidates for such studies in the future. It is also essential that the 
parasites can be maintained in domestic or experimental animals. This is because parasites 
that infect only humans cannot be maintained and expanded efficiently for clinical use.  
Another way of developing parasite-based biomedicines comes from the identification of 
effector molecules of parasites. Considerable numbers of immunomodulatory molecules 
have been identified from helminths (Harnett W & Harnett MM, 2010). The majority have 
shown therapeutic effects on experimental autoimmunity or allergy. Some investigators 
reported that viable parasites were superior to administration of the antigens of parasites 
(Hunter et al., 2010; Bodammer et al., 2011; Osada et al., 2010) in therapeutic efficacy. In 
addition, there is still considerable controversy over the roles of regulatory cells (e.g. Treg, 
Breg or AAMΦ) and regulatory cytokines (e.g. IL-4, IL-10, TGF-β) in helminth-induced 
immunomodulation. Therefore, further investigation is needed to elucidate the 
immunomodulatory mechanisms of viable parasite infections, and new findings obtained 
there should help to establish an optimal screening system for anti-autoimmune/anti-
allergic substances from parasitic helminths. 
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